ARCHIVES

EntreMed Begins Pilot Phase II Trial Of Small Molecule Angiogenesis Inhibitor.

This article is from The Cancer Letter archive.

Vol. 26 No. 46 | December 15, 2000

Download PDF Visit The Full Archive

Related Articles

In Brief: san Antonio’s ICRC Gets a New Name, SACI; Blum Is deputy Oncology Director At Kaplan

May 14, 1993

IOM Recommends FDA Consolidate Each Drug’s Lifetime History

May 4, 2012

AACR Calls For Clear Statement; Says Report Was “Premature”

February 14, 1997

NCAB, Panel May Look A Discrepancies, In Study Section Evaluation Of Grant Applications

September 4, 1981

In Brief: NCI Scientists May Run For Congress; Upton Back Heroin For Terminal Cancer Patients

September 9, 1977

Task Force Recommendations Submitted For Control/Centers New Division

August 3, 1979